The Academy seeks to engage with the EU policy process and inform decisions that affect UK medical research and the ability to collaborate across Member States.
We regularly work in partnership on these activities, including with European National Academies and our European network, the Federation of European Academies of Medicine (FEAM).
Some of our recent work has included:
- In October 2018, the Academy published a statement on the implications of leaving the EU without a deal.
- Ongoing activities around the future of the UK's research relationship with the European Union.
- Responding to the Government’s Future Partnership paper on Collaboration in science and innovation and submitting evidence to the Health Committee on Brexit – medicines, medical devices and substances of human origin inquiry and the BEIS Committee on Brexit and implications for UK business: Pharmaceuticals.
- Publishing three reports on different aspects of the relationship between UK and EU research.
- Influencing the development of EU legislation, including the Data Protection Regulation, Clinical Trials Regulation and, Medical Devices Regulation.
- Supporting FEAM to contribute to SAPEA which brings together the European Academy networks to contribute to the Science Advisory Mechanism.